CAROLE MCCORKLE: Open Payments
NPI 1730636119 · SHAWNEE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,445 in 92 payments from 16 companies in 2025. Trend: 2023 $1,914 · 2024 $1,686 · 2025 $1,445
Food & beverage: $1,445
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $293 |
| Novo Nordisk Inc | 17 | $279 |
| PFIZER INC. | 11 | $193 |
| ABBVIE INC. | 17 | $162 |
| Lilly USA, LLC | 7 | $107 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $59 |
| Viatris Specialty LLC | 1 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $37 |
Products named: NURTEC ODT, AIRSUPRA, REXULTI, FARXIGA, MOUNJARO, Ozempic, UBRELVY, Wegovy.
Industry payments across OK — which companies pay providers there.
